Home > Insider Trading > Filing (0001209191-23-033191)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1435049	Chinook Therapeutics Inc.	KDNY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1377258	Mariner William Greenman	C/O Chinook Therapeutics, Inc. 400 Fairview Ave. No., 9Th Floor Seattle WA 98109		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-26	3,300	$0.00	24,798	No	4	M	Direct
Common Stock	Disposition	2023-05-30	1,155	$23.30	23,643	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-05-26	3,300	$0.00	3,300	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-l trading plan previously adopted by the Reporting Person and represent shares by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs.
Each RSU represents a contingent right to receive one share of Issuer's common stock.
100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date.